Search by Drug Name or NDC
NDC 54092-0515-02 Intuniv 2 mg/1 Details
Intuniv 2 mg/1
Intuniv is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Takeda Pharmaceuticals America, Inc.. The primary component is GUANFACINE HYDROCHLORIDE.
Product Information
NDC | 54092-0515 |
---|---|
Product ID | 54092-515_1eef54c1-5c87-44f1-bab6-42f72d4fe0be |
Associated GPIs | 61353030107530 |
GCN Sequence Number | 065572 |
GCN Sequence Number Description | guanfacine HCl TAB ER 24H 2 MG ORAL |
HIC3 | H8M |
HIC3 Description | TX FOR ADHD - SELECTIVE ALPHA-2 RECEPTOR AGONIST |
GCN | 27578 |
HICL Sequence Number | 000120 |
HICL Sequence Number Description | GUANFACINE HCL |
Brand/Generic | Brand |
Proprietary Name | Intuniv |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | guanfacine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET, EXTENDED RELEASE |
Route | ORAL |
Active Ingredient Strength | 2 |
Active Ingredient Units | mg/1 |
Substance Name | GUANFACINE HYDROCHLORIDE |
Labeler Name | Takeda Pharmaceuticals America, Inc. |
Pharmaceutical Class | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA022037 |
Listing Certified Through | 2024-12-31 |
Package
NDC 54092-0515-02 (54092051502)
NDC Package Code | 54092-515-02 |
---|---|
Billing NDC | 54092051502 |
Package | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (54092-515-02) |
Marketing Start Date | 2009-09-02 |
NDC Exclude Flag | N |
Pricing Information | N/A |